Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

PAPERBACK
price:$31.75
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program (2008)
Board on Population Health and Public Health Practice (BPH)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "Appendix C: Meeting One Agenda." Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program. Washington, DC: The National Academies Press, 2008.

Please select a format:

Page
112


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Antivirals for Pandemic Influenza: Guidance on Developing a Distribution and Dispensing Program

2:30 pm	Health Care Worker Labor Issues
2:30 pm	Katherine Cox Health Policy Analyst American Federation of State, County and Municipal Employees International
2:45 pm	Committee Questions and Discussion with Panel
3:00 pm	Break

Panel 5:
Outbreak Prophylaxis in Emergency Service Organizations (fire, police, emergency medical services)

3:15 pm	Emergency Medical Services (EMS)
3:15 pm	Kathy Robinson Program Advisor National Association of State EMS Officials
3:30 pm	Fire
3:30 pm	John Delaney Captain Fire Department Arlington County, VA
4:00 pm	Committee Questions and Discussion with Panel
4:30 pm	Adjourn

Page
112

Front Matter (R1-R10)

Summary (1-10)

1 Introduction (11-18)

2 Antiviral Effectiveness, Safety, and Supply (19-38)

3 Ethics, Decision Making, and Communication (39-52)

4 Who Should Get Antivirals and Where? (53-86)

References (87-92)

Appendix A: Summary of Lessons Learned from Other Mass Distribution Events (93-98)

Appendix B: State Plans (99-106)

Appendix C: Meeting One Agenda (107-112)

Appendix D: Meeting Two Agenda (113-116)

Appendix E: Committee Member Biographies (117-122)